​

Funding Round

Seed Round - Granza Bio

Seed Round - Granza Bio

Investment Firm

Overview

Granza Bio is a company that developing cancer therapies based on human body's immune system.

Announced Date

Jul 03, 2024

Closed on Date

Jul 10, 2024

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Felicis

Felicis

Felicis is a early_stage_venture and late_stage_venture and seed and venture firm.

Refactor

Refactor

Refactor is a early_stage_venture and seed firm.

Participant Investors

18

Investor Name
Participant InvestorRichard Aberman
Participant InvestorEoghan McCabe
Participant InvestorEric Eldon
Participant InvestorFelicis
Participant InvestorY Combinator

Round Details and Background

Granza Bio raised $7140000 on 2024-07-03 in Seed Round

Granza Bio is a company that developing cancer therapies based on human body's immune system.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 01, 2024
Pre Seed Round - Granza Bio
1-500.0K
Jul 03, 2024
Seed Round - Granza Bio
19-7.1M

Recent Activity

There is no recent news or activity for this profile.